A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA) (NCT06864026)
A Phase 4, Prospective, Open-Label, Single-Arm Study to Assess the Effectiveness of Tirzepatide After Initiation of Ixekizumab in Adult Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice.
🩺 Plain-English Summary (8th-Grade Level)
The main purpose of this study is to assess the effectiveness of adding tirzepatide to ixekizumab therapy in standard clinical practice in participants with active PsA and obesity or overweight with at least 1 weight-related comorbidity. The study will last up to 12 months.
Who can join: Review the eligibility criteria below.
Location: AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Avondale — Avondale, Arizona
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (55 Sites)
Showing the first 25 of 55 sites.
- AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Avondale — Avondale, Arizona
- AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Chandler — Chandler, Arizona
- AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Flagstaff — Flagstaff, Arizona
- AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Gilbert — Gilbert, Arizona
- AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Glendale — Glendale, Arizona
- AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Mesa — Mesa, Arizona
- AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Phoenix PV — Phoenix, Arizona
- AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Sun City — Sun City, Arizona
- AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Tucson — Tucson, Arizona
- AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Tucson Southeast — Tucson, Arizona
- Medvin Clinical Research - Apple Valley — Apple Valley, California
- Medvin Clinical Research - Covina — Covina, California
- Newport Huntington Medical Group — Huntington Beach, California
- Purushotham & Akther Kotha MD, Inc — La Mesa, California
- Medvin Clinical Research - Riverside — Riverside, California
- Rheumatology Center of San Diego — San Diego, California
- Providence Saint John's Medical Foundation — Santa Monica, California
- Medvin Clinical Research - Temecula — Temecula, California
- Medvin Clinical Research - Tujunga — Tujunga, California
- Medvin Clinical Research - Whittier — Whittier, California
- Vida Clinical Research — Kissimmee, Florida
- Life Clinical Trials — Margate, Florida
- CZ Rheumatology — Miami Beach, Florida
- Vitalia Medical Research — Palm Beach Gardens, Florida
- International Center for Research — Tampa, Florida
📞 Contact the Study Coordinator
Phone: (317) 615-4559
Email: LillyTrials@Lilly.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Psoriatic Arthritis
- A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs — Gilbert, Arizona
- Psoriatic Arthritis D2P Screening — Philadelphia, Pennsylvania
- Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis — Dothan, Alabama
- Apremilast Pregnancy Exposure Registry — La Jolla, California
- Psorcast Mobile Study — Seattle, Washington
- A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy — Anniston, Alabama
Explore by condition: All Psoriatic Arthritis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.